Search

everythinglearnresearchcommunity

for

Search:↓

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Targeting lipid metabolism can help treat advanced, resistant cancers.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Liposomes with certain properties can effectively deliver drugs deep into hair follicles.

Polymeric micelle nanocarriers deliver adapalene more effectively to hair follicles than commercial products.

The new particle system could be a promising treatment for diseases related to the 5-α reductase enzyme.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

MVP treatment is effective and safe for recurrent breast cancer.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Liposomes improve the delivery and effectiveness of cosmetic ingredients but face challenges like cost and stability.

EV-based drug delivery shows promise but faces challenges in standardization and scalability.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

The combined treatment improves lip texture, elasticity, and firmness for up to nine months.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Nanogels with hydrophobic modifications improve oral drug delivery for intestinal disease treatment.